(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

BD 256074 - CLIA-Waived Flu A+B Combo Pack with Analyzer and Influenza A+B Test Kits

BD  # 256074 - CLIA-Waived Flu A+B Combo Pack with Analyzer and Influenza A+B Test Kits
Part Number BD 256074
SKU Number CIA8041312
Sell Unit KIT
Ships Within Special Order
List Price $872.45
Enter a valid quantity
Product Description

BD 256074 - CLIA-Waived Flu A+B Combo Pack with Analyzer and Influenza A+B Test Kits

The BD 256074 Veritor Plus CLIA-Waived Combo Pack is a comprehensive point-of-care influenza testing solution that combines the BD Veritor Plus Analyzer with BD Veritor Flu A+B CLIA-waived test kits. This package is designed to help healthcare providers perform rapid influenza A and B testing with objective digital result interpretation in a variety of clinical settings.

The combo pack includes one BD Veritor Plus Analyzer (256066) and two BD Veritor Flu A+B CLIA test kits (256045), providing a complete testing platform for healthcare facilities seeking efficient respiratory infection screening capabilities. The analyzer is designed to automate result interpretation, helping reduce subjective visual readings and supporting consistent diagnostic workflows.

This CLIA-waived system is intended for professional healthcare use in physician offices, urgent care centers, outpatient clinics, retail health clinics, occupational health facilities, and other point-of-care testing environments.

Manufacturer256074
ApplicationRespiratory Test Kit
Purchase Program TypePromotion
Test FormatTest Device Format
Time to Results10 Minute Results

Key Benefits

The BD Veritor Plus system provides rapid influenza A and B testing with automated result interpretation, helping healthcare providers make timely clinical decisions. The digital analyzer reduces reliance on visual interpretation, which may help improve result consistency and workflow efficiency.

The CLIA-waived designation simplifies implementation in eligible healthcare settings, allowing facilities to perform testing without the complexity associated with many moderate- or high-complexity laboratory procedures.

The integrated analyzer and test kit solution helps streamline point-of-care testing by combining specimen processing, result analysis, and workflow management into a single platform.

Rapid influenza detection may support timely treatment decisions, patient management strategies, and infection control efforts during seasonal flu activity.

Compatibility and Applications

The BD 256074 Combo Pack is designed for use with the included BD Veritor Plus Analyzer and BD Veritor Flu A+B CLIA test kits. The analyzer may also support additional compatible BD Veritor assays depending on facility requirements and system configuration.

Common applications include influenza screening, respiratory illness evaluation, urgent care testing, outpatient diagnostics, occupational health screening, and point-of-care infectious disease assessment.

This solution is commonly used in physician practices, urgent care clinics, community healthcare centers, student health services, outpatient facilities, and other healthcare environments requiring rapid influenza testing.

Usage Guidelines

The BD Veritor Plus CLIA-Waived Combo Pack should be used only by trained healthcare personnel following manufacturer instructions, CLIA requirements, and facility protocols. Before testing, verify analyzer functionality, test kit expiration dates, and quality control requirements.

Collect patient specimens according to the instructions provided with the BD Veritor Flu A+B test kit. Process the specimen as directed and insert the completed test device into the Veritor Plus Analyzer for automated result interpretation.

Follow all manufacturer recommendations regarding quality control, maintenance, calibration requirements, documentation, and result reporting. Do not use expired test materials or damaged components.

Certifications and Safety Standards

The BD Veritor Plus Flu A+B testing system is designed to meet applicable regulatory and quality standards for CLIA-waived diagnostic testing. The analyzer and associated test kits are manufactured under established quality management systems to support reliable diagnostic performance.

The CLIA-waived designation allows eligible healthcare facilities to perform testing under applicable federal and state regulations governing waived laboratory testing. Users should review current regulatory requirements and product documentation prior to implementation.

Comparison with Competitor Products

Compared with visually interpreted rapid influenza tests, the BD Veritor Plus Analyzer provides automated digital interpretation, helping reduce subjective result assessment and supporting standardized testing procedures.

Compared with laboratory-based influenza testing methods that may require longer turnaround times, the Veritor Plus system offers rapid point-of-care testing that can support timely clinical decision-making during patient encounters.

Compared with standalone test kits, the analyzer-based platform helps improve workflow consistency, supports electronic result management capabilities, and provides objective test interpretation.

Typical User Profile and Application Scenarios

The BD 256074 Combo Pack is commonly used by physicians, nurse practitioners, physician assistants, nurses, medical assistants, laboratory personnel, and other trained healthcare professionals involved in point-of-care diagnostic testing.

Typical application scenarios include influenza symptom evaluation, seasonal respiratory illness screening, urgent care patient assessment, occupational health testing programs, outpatient diagnostic services, and community healthcare screening initiatives.

Best Practices for Use and Maintenance

Store the analyzer and test kits according to manufacturer specifications. Monitor environmental conditions and maintain inventory controls to ensure testing materials remain within approved storage parameters.

Perform routine quality control procedures and analyzer maintenance according to manufacturer instructions. Verify operator competency and ensure all testing personnel receive appropriate training.

Maintain accurate testing records, quality control documentation, and result reporting procedures in accordance with CLIA requirements and facility policies. Regularly inspect equipment and replace consumables as recommended.

Regulatory and Safety Information

The BD Veritor Plus CLIA-Waived Combo Pack is intended for professional healthcare use only. Testing should be performed by trained personnel following manufacturer instructions, applicable CLIA regulations, infection control procedures, and institutional policies.

Users should follow standard precautions when handling patient specimens and testing materials. Appropriate personal protective equipment should be used when required, and all biological materials should be treated as potentially infectious.

Healthcare facilities should verify compliance with federal, state, and local regulations governing point-of-care testing and diagnostic device operation.

How to Order

Select the BD 256074 Veritor Plus CLIA-Waived Combo Pack Including Veritor Plus Analyzer and Veritor Flu A+B CLIA Kits and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, implementation assistance, or further product information, contact CIA Medical customer service at (312) 275-5850 or use the contact form on this page.

Related Products